Nazione: Svizzera
Lingua: italiano
Fonte: Swissmedic (Swiss Agency for Therapeutic Products)
triptorelinum
Ferring AG
L02AE04
triptorelinum
Injektionspräparat i. m./s. c.
Mikrokapsel: triptorelinum 3.75 mg ut triptorelini acetas hydricus, propylenglycoli octanoas et decanoas, poly(lactidum-co-glycolidum), pro vase. Solvens: polysorbatum 80, dextranum 70, natrii chloridum, natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
A
Biotechnologika
Hormonabhängiges Prostatico,Endometriosi,Downregulation in Reproduktionsmed.,centrale Pubertà anticipata
zugelassen
1998-09-10